CHELSEY AIKINS BELL: Open Payments
NPI 1336650662 · PROVIDENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,536 in 92 payments from 18 companies in 2025. Trend: 2023 $280 · 2024 $897 · 2025 $1,536
Food & beverage: $1,536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $351 |
| Vanda Pharmaceuticals Inc. | 12 | $270 |
| Otsuka America Pharmaceutical, Inc. | 11 | $211 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Corium, LLC | 9 | $123 |
| Axsome Therapeutics, Inc. | 7 | $84 |
| Novo Nordisk Inc | 4 | $74 |
| Lilly USA, LLC | 4 | $72 |
| Alkermes, Inc. | 3 | $65 |
| Globus Medical, Inc. | 1 | $22 |
Products named: FANAPT, REXULTI, VRAYLAR, Azstarys, UBRELVY, QULIPTA, Auvelity, LYBALVI.
Industry payments across KY — which companies pay providers there.
